In this episode of the OMG Omx podcast, Bruker's Kate Stumpo talks to Nikolai Slavov about the formidable potential offered by mass spectrometry proteomics in biomedical research, and how single-cell proteomics could open new doors for this field. Watch the full podcast or read the selected highlights below.
Nikolai Slavov | omg OMx Podcast | Ep. 7
About the Speaker
Nikolai Slavov received undergraduate education from MIT and a doctoral degree from Princeton University for characterizing the coordination of cellular growth with gene expression and metabolism.
The Slavov laboratory pioneered experimental and computational methods for single-cell proteomics and used them to connect protein covariation across single cells to functional phenotypes, including macrophage polarization, emergence of drug resistance priming, early mammalian development, and stem cell differentiation. These technologies provided a foundation for establishing Parallel Squared Technology Institute (PTI).
Prof. Slavov organizes the annual single-cell proteomics conference and contributes to organizing other leading conferences, including NeurIPS.
omg OMx host: Kate Stumpo, Senior Market Manager at Bruker
LinkedIn
About Bruker Life Sciences Mass Spectrometry
Discover new ways to apply mass spectrometry to today’s most pressing analytical challenges. Innovations such as Trapped Ion Mobility (TIMS), smartbeam and scanning lasers for MALDI-MS Imaging that deliver true pixel fidelity, and eXtreme Resolution FTMS (XR) technology capable to reveal Isotopic Fine Structure (IFS) signatures are pushing scientific exploration to new heights. Bruker's mass spectrometry solutions enable scientists to make breakthrough discoveries and gain deeper insights.